Home › Trial NCT03843294
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
- Trial IDNCT03843294
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorCatherine Bollard
- Enrollment18
- Start date2019-06-24
- ConditionsHodgkin Lymphoma · Diffuse Large B Cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.